Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway

被引:0
|
作者
Marta Szybowska
Ozgur Mete
Evan Weber
Josh Silver
Raymond H. Kim
机构
[1] University Health Network,Fred A. Litwin Family Center in Genetic Medicine
[2] University Health Network,Department of Laboratory Medicine and Pathobiology
[3] University of Toronto,Medical Genetics
[4] McGill University Health Centre,Department of Molecular Genetics
[5] University of Toronto,Division of Medical Oncology, Department of Medicine
[6] University of Toronto,Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Fred. A. Litwin Centre in Genetic Medicine
[7] University Health Network,undefined
[8] University of Toronto,undefined
来源
Endocrine Pathology | 2019年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuroendocrine neoplasms (NENs) have been primarily associated with germline pathogenic variants in genes involved in chromatin remodeling (MEN1), cell cycle control (CDKN1B), PI3K/mTOR signaling (TSC1/2, PTEN) as well as pseudohypoxia (VHL, SDHx). Recent work has implicated various genes involved in DNA repair pathways in the pathophysiology of a subset of pancreatic neuroendocrine neoplasms, including BRCA2, via the homologous recombination pathway (HRD). To date, germline variants in other HRD pathway genes have not been described to contribute to NEN. PALB2, RAD51C, and BARD1 are additional tumor suppressor genes which also mediate repair of double stranded DNA breaks through the HRD pathway and are implicated in hereditary breast (PALB2; BARD1) and ovarian (RAD51C) cancer. Here we report three cases of NEN associated with germline pathogenic variants in PALB2 (pancreatic NEN), RAD51C (thymic NEN), and BARD1 (pancreaticoduodenal NEN) respectively, further linking the DNA repair pathway to NENs.
引用
收藏
页码:237 / 245
页数:8
相关论文
共 50 条
  • [31] Pathogenic variants in genes involved in homologous recombination and mismatch repair among prostate cancer patient
    Stegel, Vida
    Skerl, Petra
    Dragos, Vita Setrajcic
    Klancar, Gasper
    Klasinc, Anja Zagozen
    Bombac, Alenka
    Hertl, Gregor
    Vogric, Vesna
    Strojnik, Ksenija
    Novakovic, Aleksander
    Blatnik, Ana
    Krajc, Mateja
    Novakovic, Srdjan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 263 - 263
  • [32] Clinical and molecular characteristics of early-stage triple-negative breast cancer (eTNBC) patients with germline pathogenic variants in homologous recombination repair genes
    Hernandez, A. Rodriguez
    Conte, B.
    Maristany, F. Braso
    Pastor, B.
    Fratini, B.
    Walbaum, B.
    Potrony, M.
    Moreno, L.
    Grau, E.
    Torres, E. Sanfeliu
    Saez, O. Martinez
    Solis, E. Segui
    Bravo, R. Gomez
    Fructuoso, I. Garcia
    Losada, M. J. Vidal
    Cajal, T. Ramon Y.
    Munoz, M.
    Balaguer, F.
    Prat, A.
    Adamo, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S334 - S334
  • [33] PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES
    Mateos, Marion K.
    Ajuyah, Pamela
    Fuentes-Bolanos, Noemi
    El Kamand, Sam
    Barahona, Paulette
    Altekoester, Ann
    Mayoh, Chelsea
    Holiday, Holly
    Liu, Jie
    Cui, Louise
    Pfaff, Elke
    Mackay, Alan
    Resnick, Adam
    Pinese, Mark
    Lau, Loretta M. S.
    Khuong-Quang, Dong-Anh
    Dias, Kimberly
    Goudie, Catherine
    Salkeld, Alison
    Rokita, Jo Lynne
    Jones, David T. W.
    Juretic, Nikoleta
    Hayden, Elisha
    Pfister, Stefan M.
    Kramm, Christof M.
    Blattner-Johnson, Mirjam
    Jabado, Nada
    Tsoli, Maria
    Vittorio, Orazio
    Mueller, Sabine
    Guo, Yiran
    Tucker, Katherine
    Waszak, Sebastian M.
    Perreault, Sebastien
    Jones, Chris
    Wong-Erasmus, Marie
    Cowley, Mark J.
    Ziegler, David S.
    NEURO-ONCOLOGY, 2024, 26
  • [34] Homologous recombination deficiency in pancreatic neuroendocrine tumors
    Bardasi, Camilla
    Tenedini, Elena
    Bonamici, Lia
    Benatti, Stefania
    Bonetti, Luca Reggiani
    Luppi, Gabriele
    Cortesi, Laura
    Tagliafico, Enrico
    Dominici, Massimo
    Gelsomino, Fabio
    FUTURE ONCOLOGY, 2024, 20 (39) : 3257 - 3266
  • [35] Young adults with neuroendocrine tumors present a high rate of pathogenic or likely pathogenic germline variants in cancer-predisposing genes
    Riechelmann, R.
    de Paula, C.
    Donadio, M.
    Santiago, K.
    de Carvalho, N.
    Carraro, D.
    Torrezan, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S236 - S237
  • [36] The Landscape of Realized Homologous Recombination in Pathogenic Bacteria
    Yahara, Koji
    Didelot, Xavier
    Jolley, Keith A.
    Kobayashi, Ichizo
    Maiden, Martin C. J.
    Sheppard, Samuel K.
    Falush, Daniel
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (02) : 456 - 471
  • [37] The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma
    Wang, Zhihai
    Zuo, Wenqi
    Zeng, Quan
    Li, Yanshi
    Lu, Tao
    Bu, Youquan
    Hu, Guohua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (03): : 408 - 419
  • [38] Germline variants in urothelial carcinoma: Analysis of pathogenic and likely pathogenic variants in 645 subjects
    Abou Alaiwi, Sarah
    Nassar, Amin
    Mouw, Kent William
    Kwiatkowski, David J.
    Choueiri, Toni K.
    Curran, Catherine
    Van Allen, Eliezer Mendel
    Esplin, Edward D.
    Yang, Shan
    Garber, Judy Ellen
    Rana, Huma Q.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Germline pathogenic variants in patients with pheochromocytoma.
    Yao, Shirley A.
    Wiley, Elizabeth A.
    Susswein, Lisa R.
    Marshall, Megan L.
    Carter, Natalie J.
    McGill, Anna K.
    Klein, Rachel T.
    Wang, Ying
    Hruska, Kathleen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Characterization of Lung Cancer with Pathogenic Germline Variants
    Kahila, Mohamed
    Gibson, Joanna
    Finberg, Karin
    Walther, Zenta
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1631 - S1631